Clinical Trials Directory

Trials / Unknown

UnknownNCT05031715

Berberine and Altered Fasting Glucose

Effectiveness of the Assumption of a Berberine Phytosoma-based Supplement on the Hematic Values of Glucose in a Group of Patients With Altered Fasting Glucose

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Azienda di Servizi alla Persona di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBerberine Phytosome2 tablets of 550 mg per day (1 before lunch and 1 before dinner)

Timeline

Start date
2020-03-02
Primary completion
2020-05-28
Completion
2022-07-25
First posted
2021-09-02
Last updated
2022-03-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05031715. Inclusion in this directory is not an endorsement.

Berberine and Altered Fasting Glucose (NCT05031715) · Clinical Trials Directory